Phone (336) 292-1510
Fax (336) 292-0679

Receive our eNewsletter

  Home  
  Our Team  
  Patient Info  
  Services  

News for Healthier Living

First patient receives neural stem cell therapy in groundbreaking UCI Health Huntington's disease clinical trial REGEN4HD

* Huntington's disease is a genetic disorder that gradually destroys brain cells over the course of 10 to 30 years, typically starting between the ages of 35 and 50 * Phase 1b/2a will evaluate the safety of the treatment and provides hope for those with few options to slow the progression of the disease * Clinical trial will enroll 21 people with early-stage Huntington's disease, with 12 participants in a phase 1b dose-escalation group and nine in a phase 2a expansion group

June 23, 2026


July 1 2026

June 30 2026

June 29 2026

June 26 2026

June 25 2026

June 24 2026

June 23 2026

June 22 2026

June 21 2026

June 19 2026

June 18 2026

June 17 2026